TFF3 and PVRL2 co-targeting identified by multi-omics approach as an effective cancer immunosuppression strategy.

Q: How does OCRA curate its research paper database?

OCRA indexes peer-reviewed papers from PubMed and CrossRef, enriched with MeSH terms, author profiles, and citation metrics. Papers are categorized by cancer type, research method, and clinical relevance.

Q: Can I search papers by MeSH term or author?

Yes. Use the search bar to filter papers by MeSH term, author name, journal, keyword, or cancer type. Each paper includes linked MeSH terms and author profiles for further exploration.

Q: How current is the paper database?

The database is updated regularly through automated ingestion from PubMed and CrossRef. Most papers appear within days of their PubMed indexing date.

doi:10.1016/j.lfs.2024.123113

TFF3 and PVRL2 co-targeting identified by multi-omics approach as an effective cancer immunosuppression strategy.

Peng Huang & Vijay Pandey et al. · 2024

6Citations

Links

DOI

Journal

Unknown Journal

TL;DR

PVRL2 has emerged as a promising immunoinhibitory target with significant associations with TFF3 and represents a key co-targetable molecule for effective oncotherapeutic strategies.

AI-generated by Semantic Scholar

Authors

Peng Huang, Tesfaye Wolde, Vipul Bhardwaj, Xi Zhang, Vijay Pandey